Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Accrued Investment Income Receivable by Year
Accrued Investment Income Receivable ($M)
Elevance Health Accrued Investment Income Receivable: $295M in FY2025, up 2.8% from a year earlier.
Latest, FY2025
295
Period ended Dec 31, 2025
Change on a year earlier
+2.8%
287 in FY2024
History
12 years
Since FY2014
Sources
2
Documents cited below
Where the FY2025 figure comes from
“us-gaap:AccruedInvestmentIncomeReceivable (2025-12-31): 295,000,000.00”
Source: ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Elevance Health Accrued Investment Income Receivable ($M), annual FY2014–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-accrued-investment-income
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.